Enanta Pharmaceuticals (ENTA) Stock Research

Today

Enanta reports Q3 EPS (67c), consensus (51c)

ENTA

4:04 PM

Over a week ago

Enanta announces European Commission approval of Maviret

ENTA

Jun 23, 5:56 AM

Enanta to advance zelicapavir into registrational Phase 2b/3 clinical trial

ENTA

Jun 18, 7:06 AM

Enanta reports Q2 EPS (45), consensus (49c)

ENTA

May 11, 4:02 PM

Enanta announces first participant dosed in Phase 1 trial of EDP-978

ENTA

Apr 13, 7:04 AM

Enanta initiated with bullish view at Rodman & Renshaw

ENTA

Mar 26, 7:42 AM

Enanta files $150M mixed securities shelf

ENTA

Feb 11, 4:45 PM

Enanta reports Q1 EPS (42c), consensus (88c)

ENTA

Feb 9, 4:02 PM

Enanta reports Q4 EPS (87c), consensus ($1.01)

ENTA

Nov 17, 4:02 PM

Enanta initiated with bullish view at JPMorgan, here's why

ENTA

Nov 14, 4:53 AM

Enanta upgraded to Buy at Jefferies on higher confidence in RSV antiviral

ENTA

Oct 1, 10:25 AM

Jefferies gets more bullish on Enanta, upgrades shares

ENTA

Oct 1, 10:21 AM

Enanta 6.5M share Spot Secondary priced at $10.00

ENTA

Sep 30, 9:17 PM

Closing Bell Movers: Nike rallies 4% after earnings beat and guidance

+14

Sep 30, 7:48 PM

Enanta $50M Spot Secondary; price range $10.00-$10.50

ENTA

Sep 30, 4:18 PM

Enanta announces $50M common stock offering

ENTA

Sep 30, 4:14 PM

Enanta reports 'positive' results from Phase 2b study of zelicapavir

ENTA

Sep 29, 6:31 AM

Enanta announces passing of CFO Paul Mellet Jr.

ENTA

Sep 3, 6:04 AM

Enanta initiated with bullish view at WestPark Capital

ENTA

Sep 2, 7:05 AM

Enanta files EU patent infringement suit against Pfizer

Aug 20, 7:08 AM

Enanta price target raised by $1 at Citizens JMP, here's why

ENTA

Aug 12, 5:51 AM

Enanta reports Q3 EPS (85c), consensus (88c)

ENTA

Aug 11, 4:03 PM

No more stories